Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement

8 Aug 2011 16:35

The Income & Growth VCT plc ("the Company") INTERIM MANAGEMENT STATEMENT For the quarter ended 30 June 2011

In accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority, The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 June 2011. The statement also includes relevant financial information between the end of the period and the date of this statement.

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30 June 2011 At 31 March 2011 Net assets attributable to shareholders Β£42,089,235 Β£39,518,614 Shares in issue 40,959,238 39,479,195 Net asset value (NAV) per share * 102.8 p 100.1 p Cumulative dividends paid to date per share 4.5 p 4.5 p Total return per share since inception (NAV 107.3 p 104.6 pbasis)* -------------------------------------- * NAV per share includes current year income of 1.8 p 0.6 p

NEW INVESTMENTS AND DIVESTMENTS

The VCT received final loan stock repayments of Β£166,667 from Camwood Enterprises Limited and Β£204,654 plus a premium of Β£51,164 from MachineWorks Software Limited in April 2011.

No new investments or further divestments were made during the quarter. The following investment activity has however taken place after the period-end in July 2011:-

A further loan stock investment of Β£106k into Monsal Holdings Limited has been committed by the Company, alongside other Matrix VCTs and other shareholders, to provide Β£1.75 million to fund a working capital need resulting from completion delays in an existing contract and in obtaining new contracts. The first tranche of this new investment, Β£28,297, was drawn down in July and a further tranche of Β£14,149 is due to be drawn down shortly.

The VCT completed an investment of Β£1,718,189 to support the MBO of Motorclean Group, the UK's leading provider of vehicle cleaning and valet services to the car dealership market, partly using the Company's existing investment of Β£1 million in the acquisition vehicle Fullfield Limited.

The Company has fully realised its investment in Amaldis (2008) Limited, the holding company for the Original Additions Group. The VCT's investment was sold to LDC, for net proceeds of Β£2.3 million, comprising capital proceeds of Β£1.9 million (including Β£538k of loan stock issued by the acquirer) and interest of Β£427k, on 18 July 2011. This realisation contributed to total proceeds of Β£4.2 million to the Company over the life of the investment, representing a 4.2 times return on the Company's original investment of Β£1 million.

A final loan stock repayment of Β£166,667 was received from AppDNA Limited.

SHARE BUY-BACKS

During the quarter the VCT bought back a total of 323,875 of the Company's own shares at an average price of 89.0 pence per share. No further shares have been bought back by the Company since the period-end.

MATRIX VCTs' JOINT OFFER FOR SUBSCRIPTION

During the quarter, the Company issued and allotted a total of 1,803,918 ordinary shares at a price of Β£1.058 per share, raising net proceeds of Β£1.8 million.

Since the quarter end the Company has allotted a further 153,791 ordinary shares at a price of Β£1.06 per share, raising further net proceeds of Β£154k.

The Offer closed on 30 June 2011 having raised a total of 5.2 million (net) for the Company.

For further information, please contact:

Sarah Penfold, for Matrix Private Equity Partners LLP, Company Secretary: 020 3206 7000

XLON
Date   Source Headline
20th Dec 20194:00 pmRNSFundraising Update
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
16th Dec 20199:45 amRNSTransaction in Own Shares
13th Dec 20194:30 pmRNSAnnual Financial Report
6th Dec 20194:45 pmRNSDividend Investment Scheme - Recommencement
6th Dec 20194:45 pmRNSAnnual Results for the year ended 30 Sep 2019
26th Nov 20194:09 pmRNSDirector Declaration
14th Nov 201912:00 pmRNSFundraising Update
12th Nov 20192:30 pmRNSDirectorate Change
25th Oct 20194:00 pmRNSPublication of a Prospectus
18th Oct 20195:20 pmRNSDirectorate Change
3rd Oct 20199:52 amRNSDirector Declaration
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
18th Sep 20194:01 pmRNSDividend Declaration
10th Sep 20195:00 pmRNSFundraising Update, Circular and General Meetings
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
13th Aug 20193:19 pmRNSInterim Management Statement - 3rd Quarter
31st Jul 20197:00 amRNSReduction of Capital
29th Jul 201911:00 amRNSShare buyback policy objective
29th Jul 20197:00 amRNSIntention to launch offers for subscription
2nd Jul 20199:11 amRNSRealisation of investment
7th Jun 20195:35 pmRNSTransaction in Own Shares
5th Jun 20194:44 pmRNSTransaction in Own Shares
4th Jun 201911:05 amRNSHalf-year Report
30th May 20193:38 pmRNSHalf-year Report
26th Mar 20195:25 pmRNSTransaction in Own Shares
15th Feb 20194:30 pmRNSTransaction in Own Shares
6th Feb 20191:54 pmRNSInterim Management Statement - 1st Quarter
6th Feb 20191:42 pmRNSResult of AGM
19th Dec 20184:32 pmRNSTransaction in Own Shares
19th Dec 20183:50 pmRNSAnnual Financial Report
17th Dec 20189:25 amRNSTransaction in Own Shares
12th Dec 20182:25 pmRNSDividend Investment Scheme - Suspension
12th Dec 20182:24 pmRNSFinal Results for year ended 30 September 2018
26th Sep 20184:54 pmRNSTransaction in Own Shares
13th Sep 201811:59 amRNSInterim Management Statement to 30 June 2018
14th Aug 20189:42 amRNSNet Asset Value(s)
20th Jul 20185:41 pmRNSTransaction in Own Shares
2nd Jul 20184:18 pmRNSTotal Voting Rights
21st Jun 20184:24 pmRNSDirector/PDMR Shareholding
21st Jun 20184:20 pmRNSDirector/PDMR Shareholding
21st Jun 20184:19 pmRNSIssue of Equity
11th Jun 201811:13 amRNSTransaction in Own Shares
15th May 201812:59 pmRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.